In a recent study, using network neuroscience, investigators found a way to objectively determine the balance of integration and segregation in fMRI-measured brain signals during wakefulness as well as during sleep and anesthesia.

A urologic oncologist answers questions about prostate cancer.

A study finds that efforts to cap prescription drug spending are yielding significant out-of-pocket savings for these patients.

Investigators at Michigan Medicine, who are studying the nature of consciousness, have successfully used the drug to identify the intricate brain geometry behind the unconscious state, offering an unprecedented look at brain structures that have traditionally been difficult to study.

University of Michigan Health ranks among the nation’s best hospitals in more specialties than any other Michigan hospital, according to U.S. News and World Report’s Best Hospitals Rankings for 2024-2025.

A medical student and surgery faculty member studied the longevity of depression symptoms developed by first-year resident trainees. With their findings now published, they hope to use this data to destigmatize conversations about physician mental health and pave the way for better cultural and institutional support.

Medical students have worked to place dispensers at parks, pools and golf courses around Washtenaw County to give people easy access to sunscreen.

Today on The Fundamentals is Dr. Maria Castro, the R.C. Schneider collegiate professor of neurosurgery, and a professor of cell and developmental biology at the University of Michigan Medical School. Her research program aims to develop immunotherapies for primary and metastatic brain cancer, studying basic immune biology mechanisms leading to clinical implementation. She has been inducted into the American Association for the Advancement of Sciences, the Latin American Academy of Sciences, and the American Institute for Medical and Biological Engineering College of Fellows. She has won numerous awards for her contributions to basic science and cancer research and is a diversity ambassador for the Cancer Biology Graduate Training Program. You can learn more about Dr. Castro here, and you can follow her @castro2355_mg, the Rogel Cancer Center @UMRogelCancer, the department of neurosurgery @umichneuro, Michigan Neurscience Institute @UM_MNI and the department of cell and developmental biology @UMCDB on X

The Clinical Trials Support Office (CTSO) is pleased to announce that Mio Nakamura, MD, MS, Clinical Assistant Professor, Dermatology, has been appointed as the new Associate Medical Director of the Michigan Clinical Trials Support Unit (M-CTSU) and Michigan Clinical Research Unit (MCRU). Dr. Nakamura’s appointment will begin July 1, 2024, and is a 2-year term.

George A. Mashour, M.D., Ph.D., has been appointed senior associate dean for faculty and faculty development of the University of Michigan Medical School by the U-M Board of Regents, effective May 1, 2024.

Patients can now enroll in a clinical trial to test a groundbreaking nonsurgical treatment for cervical lesions that affect nearly 300,000 women in the United States every year.

With over 400 stories published on Health Lab in 2023, the following 10 articles were the most read of the year.

Recently approved by the Food and Drug Administration, Pluvicto is a radionuclide-labelled drug administered to patients showing promising results.

The holidays are a great time to discuss your family's medical history. Learn the importance of discussing your family's health history & how to bring it up.